alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# ATLANTIC BANCSHARES,
INC.

Exhibit 32

# CERTIFICATION PURSUANT
TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

The  undersigned,  the Chief  Executive  Officer  and  Principal  Financial  Officer  of  Atlantic  Bancshares,  Inc.  (the
"Company"), certifies that, to his knowledge on the date of this certification:

| | 1. | The quarterly report of the Company for the period ended March 31, 2009 as
          filed with the Securities and Exchange Commission on this date (the
          Report) fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | 2. | The information contained in the Report fairly presents, in all material
          respects, the financial condition and result of operations of the Company.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------

|Date:  May 15, 2009 |  | By:   /s/  Robert P. Trask
|------------------- |  | --------------------------
|                    |  | Robert P. Trask           
|                    |  | Chief Executive Officer   

|Date:  May 15, 2009 |  | By:   /s/  Michelle M. Pennell
|------------------- |  | ------------------------------
|                    |  | Michelle M. Pennell           
|                    |  | Principal Financial Officer
[Federal Register Volume 77, Number 52 (Friday, March 16, 2012)]
[Notices]
[Pages 15782-15783]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-6345]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The purpose of this meeting is to evaluate requests 
for preclinical development resources for potential new therapeutics 
for the treatment of cancer. The outcome of the evaluation will provide 
information to internal NCI committees that will decide whether NCI 
should support requests and make available contract resources for 
development of the potential therapeutic to improve the treatment of 
various forms of cancer. The research proposals and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material and personal information concerning individuals 
associated with the proposed research projects, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.


[[Page 15783]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel NCI Experimental Therapeutics Program (NExT).
    Date: April 11, 2012.
    Time: 8:30 a.m.-4:30 p.m.
    Agenda: To evaluate the NCI Experimental Therapeutics Program 
Portfolio.
    Place: National Institutes of Health, Neuroscience Building, 
6001 Executive Boulevard, Room C, Bethesda, MD 20814.
    Contact Person: Barbara Mroczkowski, Ph.D., Executive Secretary, 
NCI Experimental Therapeutics Program, National Cancer Institute, 
NIH 31 Center Drive, Room 3A44, Bethesda, MD 20817, (301) 496-4291, 
<a href="/cdn-cgi/l/email-protection#f29f809d9188999d8581999b90b29f939b9edc9c9b9adc959d84"><span class="__cf_email__" data-cfemail="92ffe0fdf1e8f9fde5e1f9fbf0d2fff3fbfebcfcfbfabcf5fde4">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 9, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-6345 Filed 3-15-12; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>
                                                                    EXHIBIT 32.2

      CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT
                TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Caribou Coffee Company, Inc.
(the "Company") on Form 10-Q for the quarter ended October 2, 2005, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, George E. Mileusnic, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)  The Report fully complies with the requirements of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.

November 14, 2005


                                               /s/ George E. Mileusnic
                                               --------------------------------
                                               George E. Mileusnic
                                               Chief Financial Officer
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

___________________

No. 96-50845

Summary Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

ISMAEL CARRILLO-MARQUEZ,

Defendant-Appellant.

- - - - - - - - - -

Appeal from the United States District Court

for the Western District of Texas

USDC No. EP-96-CR-400-ALL

- - - - - - - - - -

September 10, 1997

Before JOLLY, BENAVIDES and PARKER, Circuit Judges.

PER CURIAM:*

Ismael Carrillo-Marquez (“Marquez”) appeals his jury

conviction for importation of cocaine and for possession with

intent to distribute cocaine. Our review of the record and the

arguments and authorities convinces us that no reversible error

was committed. The evidence was sufficient to support the jury’s

verdict. See United States v. Ivey, 949 F.2d 759, 766 (5th Cir.
No. 96-50845

-2-

1991). The district court did not plainly err by failing to give

a separate jury instruction on the definition of “knowingly.” 

See United States v. Sanchez-Sotelo, 8 F.3d 202, 212 (5th Cir.

1993).

AFFIRMED.
Order entered June 3, 2014

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-00310-CV

ROBERT TREJO, Appellant

V.

SAMANTHA HUY, Appellee

On Appeal from the 101st Judicial District Court

Dallas County, Texas

Trial Court Cause No. DC-12-05068

ORDER

We GRANT appellant’s May 30, 2014 unopposed second motion for an extension of 

time to file a brief. Appellant shall file his brief on or before July 3, 2014. We caution appellant 

that no further extension of time will be granted absent extraordinary circumstances.

/s/ ADA BROWN 

JUSTICE
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2160 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2160

 To suspend temporarily the duty on ion exchange resin, tertiary amine 
                        crosslinked polystyrene.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 29, 2009

Mr. Specter (for himself and Mr. Casey) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To suspend temporarily the duty on ion exchange resin, tertiary amine 
                        crosslinked polystyrene.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ION EXCHANGE RESIN, TERTIARY AMINE CROSSLINKED POLYSTYRENE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Ion exchange        Free         No change        No change        On or before 12/  ''.
                        resin, tertiary                                                    31/2011.......
                        amine crosslinked
                        polystyrene (CAS
                        No. 68441-29-2)
                        (provided for in
                        subheading
                        3914.00.60)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
#### Mark W. Muzroll et al., Respondents, v James Wilson, Appellant.

In a negligence action to recover damages for personal injuries, the defendant appeals from an order of the Supreme Court, Suffolk County (Lama, J.), entered October 4, 1989, which granted the plaintiffs’ motion to direct the defendant’s insurer to comply with an "amended infant’s compromise order” dated July 6, 1987.

Ordered that the order is affirmed, with costs.

The defendant never moved to vacate, amend, or modify the "amended infant’s compromise order” *(see,*CPLR 5015). He first raised an objection to the terms of that order in opposition to the plaintiff’s motion to compel his compliance with the order, approximately two years after it was issued. As such, the defendant has waived any objection he may have had to the amended order *(see, Matter of MVAIC v Marrero,*17 NY2d 342).

We have considered the defendant’s remaining contentions and find them to be without merit. Mangano, P. J., Bracken, Kunzeman and Miller, JJ., concur.
#### Willie Vaughn by his next friend, A. C. Clewis. Plaintiff in Error, vs. Peninsular Telephone Company, a corporation, Defendant in Error.

(Supreme Court of Florida, *En Banc,*

July 12, 1905.)

Writ of Error to Circuit Court, Hillsborough County; Joseph B. Wall, Judge.

*P. O. KnigM*and *E. C. Gordon,*for Plaintiff in Error.

*J. J. Lunsford,*for Defendant in Error.

*618Decision

Per Curiam.

This action was brought by the plaintiff in error against the defendant in error. There was judgment for the defendant and the plaintiff takes writ of error. The judgment is affirmed.
### Appendix B



## AERO DRONE RESOURCES LLC.

MISSION & AIRCRAFT CHECKLIST

DATE

............................. TIME

.............................

AIRCRAFT

..........................................................

LOCATION

..........................................................

REFERENCE

.......................................................

Documents:

OPS Manual A ccessible

Exception Doc. Available

Aircraft Log Book Maintenance status

PIC docs A ccessible

Permits Available

Certificate of Waiver or Authorization (COA) Available

Environment:

Weather report & forecast C heck ed

TFR's C heck ed

N otams C heck ed

Obstructions C heck

Aircraft:

Manual Within reach

Squawks Check prior entries

Battery co ndition and capacity Check*

Blades/ Ro tors/Motors C heck for damage

Disc repancies Record if any

Ma rkings C heck

Flight Rou te program Verify

Elev ations C heck

*Battery should show 100% charge before the

operation starts

Ground Control S tation:

Ops Manual A vailable

Battery condition capacity Check

Radio range Check

Perimeter security Orange Cones 30’

Fire Exti nguisher Condition and within reach

VHF Transceiver** Charged and tuned to frequency

The ground control station area is the center of each

operation and should be treated as sterile cockpit Shut down and Securing :

Times Recorded

Squawks Recorded

Batteries*** Removed & Stored

***Batteries should be transported in Fire resistant

containers.



### NOTES:



### ____________________________________

_______________________ ____________ _

____________________________________

____________________________________

____________________________________

____________________________________

____________________________________

___ _________________________________

____________________________________

____________________________________

____________________________________

Aero Drone Resources Llc

– (503) 857 3530
Exhibit 35.4

SERVICER COMPLIANCE STATEMENT

American Express Centurion Bank

American Express Credit Account Master Trust

Reporting Period January 1, 2011 to December 31, 2011

The undersigned, each a duly
authorized officer of American Express Centurion Bank (AECB), a wholly-owned subsidiary of American Express Travel Related Services Company, Inc. (TRS), pursuant to the Amended and Restated Supplemental Servicing Agreement,
dated as of March 30, 2010, among TRS, AECB, American Express Bank, FSB, American Express Receivables Financing Corporation III LLC, American Express Receivables Financing Corporation IV LLC, and American Express Receivables Financing
Corporation II (the Agreement), does hereby certify that:

1. AECB performs certain servicing procedures on behalf of TRS under
the Agreement.

2. The undersigned is duly authorized to execute and deliver this Certificate.

3. A review of AECBs activities during the reporting period and of its performance under the Agreement has been made under my supervision.

4. To the best of my knowledge, based on such review, AECB has fulfilled all of its obligations under the Agreement in all material respects
throughout the reporting period.

IN WITNESS WHEREOF, the undersigned has duly executed this Certificate this 20thday of March, 2012.



|                                |  |                            
|------------------------------- |  | ---------------------------
|AMERICAN EXPRESS CENTURION BANK
|                                | 
|By:                             |  | /s/ Kevin L. Thompson      
|Name:                           |  | Kevin L. Thompson          
|Title:                          |  | Chief Financial Officer    
|                               
|AMERICAN EXPRESS CENTURION BANK
|                                | 
|By:                             |  | /s/ Paul A. Thompson       
|Name:                           |  | Paul A. Thompson           
|Title:                          |  | Vice President  Controller
Exhibit 32.2


  Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350,
      as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly  Report on Form 10-QSB of Utilicraft  Aerospace
Industries,  Inc. (the  "Company") for the quarter ended  September 30, 2007, as
filed with the  Securities  and  Exchange  Commission  on the date  hereof  (the
"Report"),  I, Randy Moseley,  Chief Financial Officer of the Company,  certify,
pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.


   Date: November 13, 2007
                                                       /s/ Randy Moseley
                                                       -----------------------
                                                       Randy Moseley
                                                       Chief Financial Officer
Skip to main content (Press Enter).
 Toggle navigation
            
            
            
            U.S. Air Force
                    U.S. Air Force
        Search
                    Search AF.mil:
                        Search
                Search AF.mil:
                    Search
    News
    
        Commentaries

    Features

    Photos

    Art

    Air Force TV

    Radio

    Week in Photos

    Coronavirus Disease 2019

    Air Force Art Collection





    About Us
    
        Air Force Senior Leaders    
        SECAF

    CSAF

    CMSAF

    Biographies

    Adjunct Professors

    Fact Sheets

    Commander's Call Topics    
        CCT Archive

    50 Years of the CMSAF

    The Book

    Speeches Archive    
        Former AF Top 3 Viewpoints and Speeches

    Air Force Warrior Games 2019

    Air Force Strategic Documents

    DoD Warrior Games

    Portraits in Courage    
        Portraits In Courage Vol. I

    Portraits In Courage Vol. II

    Portraits In Courage Vol. III

    Portraits In Courage Vol. IV

    Portraits In Courage Vol. V

    Portraits In Courage Vol. VI

    Portraits In Courage Vol. VII

    Portraits In Courage Vol. VIII

    Portraits In Courage Vol. IX

    Portraits In Courage Vol. X

    Chapman MoH

    The Air Force We Need

    Events 2021

    Focus on Priorities

    Empowered Airmen

    State Licensure Portability

    CSAF Leadership Library    
        CSAF Leadership Library Bookshelf

    2018 CSAF Reading List

    2017 CSAF Reading List

    2016 CSAF Reading List





    AF Sites
    
        Social Media Sites

    Site Registration





    AF Content Management





    Careers





    Contact Us  
 Home
  News
  Photos
 Air Force Photos Search
 Search
 Upload Date Upload DatePhoto DateTitle
  Full Size (0.61 MB)
 Photo Gallery
 Quick Links
                            Join the Air ForceSite MapQuestionsContact UsRSSFOIAIGAF SitesAccessibilityEEOLink DisclaimerStrategic APRSuicide PreventionSAPRUSA.govNo FEAR ActOSI Tip Line
                    Connect
                    Official United States Air Force Website
                        Subscribe to USAF News and Information
          Submit
EXHIBIT 32.1

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Cougar Biotechnology, Inc. does hereby certify that, to his knowledge:



| | (a) | the Quarterly Report on Form 10-Q of Cougar Biotechnology, Inc. for the quarter ended March 31, 2008 (the Report) fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (b) | information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Cougar Biotechnology, Inc.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------



|                   |  |  |  |     |  |                      |  |                                      
|------------------ |  |  |  | --- |  | -------------------- |  | -------------------------------------
|                   |  |  | 
|Date: May 12, 2008 |  |  |  | By: |  | /s/ ALAN H. AUERBACH
|                   |  |  |  |     |  |                      |  | Alan H. Auerbach                     
|                   |  |  |  |     |  |                      |  | President and Chief Executive Officer
<TABLE> <S> <C>

<ARTICLE>                                      5
<CIK>                                                         0000949373
<NAME>                             New World Coffee-Manhattan Bagel, Inc.
       
<S>                                              <C>
<PERIOD-TYPE>                                                     12-MOS
<FISCAL-YEAR-END>                                            DEC-28-1999
<PERIOD-START>                                               JAN-01-1998
<PERIOD-END>                                                 DEC-28-1998
<CASH>                                                         5,269,627
<SECURITIES>                                                           0
<RECEIVABLES>                                                  3,067,688
<ALLOWANCES>                                                           0
<INVENTORY>                                                    1,355,730
<CURRENT-ASSETS>                                              11,532,171
<PP&E>                                                         6,889,876
<DEPRECIATION>                                                 1,463,456
<TOTAL-ASSETS>                                                38,093,437
<CURRENT-LIABILITIES>                                         11,062,681
<BONDS>                                                       13,530,749
<PREFERRED-MANDATORY>                                                  0
<PREFERRED>                                                            0
<COMMON>                                                          19,443
<OTHER-SE>                                                     8,923,700
<TOTAL-LIABILITY-AND-EQUITY>                                  38,093,437
<SALES>                                                       14,554,387
<TOTAL-REVENUES>                                              17,282,524
<CGS>                                                         12,463,894
<TOTAL-COSTS>                                                  3,461,839
<OTHER-EXPENSES>                                                       0
<LOSS-PROVISION>                                                 198,331
<INTEREST-EXPENSE>                                               925,467
<INCOME-PRETAX>                                               (7,491,610)
<INCOME-TAX>                                                           0
<INCOME-CONTINUING>                                           (7,491,610)
<DISCONTINUED>                                                         0
<EXTRAORDINARY>                                                        0
<CHANGES>                                                              0
<NET-INCOME>                                                  (7,491,610)
<EPS-PRIMARY>                                                      (0.55)
<EPS-DILUTED>                                                      (0.55)
        



</TABLE>